Primary |
Epilepsy |
40.2% |
Convulsion |
21.6% |
Bipolar Disorder |
7.0% |
Depression |
5.0% |
Partial Seizures |
4.1% |
Hypertension |
4.0% |
Trigeminal Neuralgia |
2.6% |
Affective Disorder |
2.2% |
Anxiety |
1.7% |
Pain |
1.7% |
Complex Partial Seizures |
1.4% |
Neuralgia |
1.3% |
Insomnia |
1.1% |
Diabetes Mellitus |
1.0% |
Attention Deficit/hyperactivity Disorder |
0.9% |
Bipolar I Disorder |
0.9% |
Psychotic Disorder |
0.8% |
Multiple Sclerosis |
0.8% |
Petit Mal Epilepsy |
0.8% |
Arrhythmia |
0.8% |
|
Convulsion |
14.1% |
Vomiting |
11.5% |
Death |
7.7% |
Hyponatraemia |
7.2% |
Tremor |
5.9% |
Weight Increased |
5.7% |
Maternal Exposure During Pregnancy |
5.5% |
Somnolence |
5.2% |
Weight Decreased |
4.7% |
Drug Exposure During Pregnancy |
3.9% |
Speech Disorder |
3.5% |
Product Substitution Issue |
3.3% |
Surgery |
3.2% |
Vision Blurred |
3.0% |
Suicidal Ideation |
2.8% |
Petit Mal Epilepsy |
2.7% |
Epilepsy |
2.6% |
Rash |
2.6% |
Suicide Attempt |
2.5% |
Urinary Tract Infection |
2.5% |
|
Secondary |
Epilepsy |
29.1% |
Convulsion |
15.0% |
Product Used For Unknown Indication |
9.4% |
Drug Use For Unknown Indication |
8.1% |
Bipolar Disorder |
7.5% |
Depression |
5.8% |
Hypertension |
3.7% |
Pain |
2.9% |
Anxiety |
2.8% |
Partial Seizures |
2.5% |
Sleep Disorder |
1.8% |
Bipolar I Disorder |
1.8% |
Insomnia |
1.6% |
Agitation |
1.4% |
Complex Partial Seizures |
1.3% |
Diabetes Mellitus |
1.1% |
Neuralgia |
1.1% |
Trigeminal Neuralgia |
1.1% |
Drug Exposure During Pregnancy |
1.0% |
Affective Disorder |
1.0% |
|
Vomiting |
15.0% |
Hyponatraemia |
9.3% |
Weight Increased |
9.1% |
Somnolence |
8.2% |
Tremor |
7.4% |
Weight Decreased |
7.4% |
Convulsion |
5.1% |
Suicide Attempt |
4.4% |
Vision Blurred |
3.9% |
Petit Mal Epilepsy |
3.6% |
Tachycardia |
3.6% |
Nausea |
3.1% |
Maternal Exposure During Pregnancy |
2.8% |
Nervousness |
2.6% |
Death |
2.5% |
Syncope |
2.5% |
Treatment Noncompliance |
2.5% |
Urinary Tract Infection |
2.3% |
Visual Impairment |
2.3% |
Swelling Face |
2.2% |
|
Concomitant |
Product Used For Unknown Indication |
18.6% |
Bipolar Disorder |
12.4% |
Epilepsy |
10.2% |
Depression |
8.2% |
Convulsion |
7.6% |
Drug Use For Unknown Indication |
6.4% |
Anxiety |
5.1% |
Multiple Sclerosis |
4.9% |
Pain |
4.1% |
Hypertension |
3.3% |
Sleep Disorder |
3.3% |
Insomnia |
2.3% |
Schizophrenia |
2.2% |
Smoking Cessation Therapy |
2.1% |
Affective Disorder |
1.9% |
Gastrooesophageal Reflux Disease |
1.6% |
Rheumatoid Arthritis |
1.6% |
Attention Deficit/hyperactivity Disorder |
1.5% |
Psychotic Disorder |
1.4% |
Contraception |
1.3% |
|
Weight Increased |
16.3% |
Vomiting |
11.5% |
Type 2 Diabetes Mellitus |
10.4% |
Convulsion |
9.1% |
Weight Decreased |
6.5% |
Tremor |
5.9% |
Drug Ineffective |
3.9% |
Somnolence |
3.9% |
Suicidal Ideation |
3.7% |
Rash |
3.5% |
Nausea |
3.3% |
Vision Blurred |
2.8% |
Type 1 Diabetes Mellitus |
2.7% |
Urinary Tract Infection |
2.6% |
Diabetes Mellitus |
2.6% |
Pyrexia |
2.4% |
Pancreatitis |
2.3% |
Wrong Technique In Drug Usage Process |
2.3% |
Syncope |
2.2% |
Headache |
2.2% |
|
Interacting |
Epilepsy |
28.0% |
Product Used For Unknown Indication |
9.1% |
Bipolar Disorder |
7.7% |
Pain |
7.0% |
Drug Use For Unknown Indication |
5.6% |
Post Herpetic Neuralgia |
4.2% |
Smoking Cessation Therapy |
4.2% |
Convulsion |
3.5% |
Depression |
3.5% |
Anxiety |
2.8% |
Burning Sensation |
2.8% |
Hypertension |
2.8% |
Schizophrenia, Paranoid Type |
2.8% |
Trigeminal Neuralgia |
2.8% |
Type 1 Diabetes Mellitus |
2.8% |
Abnormal Behaviour |
2.1% |
Acne |
2.1% |
Contraception |
2.1% |
Fibromyalgia |
2.1% |
Hirsutism |
2.1% |
|
Drug Interaction |
19.1% |
Overdose |
12.8% |
Vomiting |
8.5% |
Hyponatraemia |
6.4% |
Inappropriate Antidiuretic Hormone Secretion |
6.4% |
Pain |
6.4% |
Granulocytopenia |
4.3% |
Hypothermia |
4.3% |
Postictal State |
4.3% |
Sleep Disorder |
4.3% |
Wrong Drug Administered |
4.3% |
Blood Pressure Decreased |
2.1% |
Chills |
2.1% |
Convulsion |
2.1% |
Delirium |
2.1% |
Diarrhoea |
2.1% |
Dizziness |
2.1% |
Drug Level Changed |
2.1% |
Drug Prescribing Error |
2.1% |
Encephalopathy |
2.1% |
|